SCHEMBL9769264

SCHEMBL9769264

CC(C)C(=O)Nc1ccc(C(CO)NC(C)(C)C)cn1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
RAB9A P51151 6/20 0.43
NPC1 O15118 5/20 0.43
TP53 P04637 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALOX15 P16050 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
FFAR2 O15552 1/20 0.39
ADRB2 P07550 1/20 0.39
MAPT P10636 1/20 0.38
DEGS1 O15121 2/20 0.38
TSHR P16473 2/20 0.38
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19728673 0.77 DEGS1 (0.54) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL9769356 0.77 ALDH1A1 (0.45) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL9891790 0.70 RAB9A (0.68) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL9769258 0.68 RAB9A (0.55) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL19699480 0.68 FFAR2 (0.62) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL29854856 0.68 RAB9A (0.55) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL19699552 0.68 L3MBTL1 (0.68) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL9893012 0.68 RAB9A (0.57) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL9769174 0.68 ALDH1A1 (0.49) ALDH1A1RAB9ANPC1TP53SMN1; SMN2
SCHEMBL3466199 0.68 ALDH1A1 (0.50) ALDH1A1RAB9ANPC1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5019578-A β-adrenergic agonists MERCK & CO., INC. (US) 1991-05-28 US disclosed
EP-0318092-A2 Novel beta-adrenergic agonists MERCK & CO. INC. (US) 1989-05-31 EP disclosed